In contrast to LGG, the OPN3 gene was expressed at a higher level in GBM, which was consistent with the expression trend of OPN3 protein levels increasing gradually from grade II (LGG) to IV (GBM) glioma. This evidence concerns the gene OPN3 and central nervous system cancer.